Google Übersetzer
Syngene International Limited
About
Syngene International Limited (NSE:SYNGENE) — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 19 2026
VivaMed BioPharma Partners With Syngene International to Advance AI-Derived Repurposed Therapeutic Programs Through Global Validation Infrastructure
Jan 22 2026
Press Release Jan 22 2026
Jan 20 2026
Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
Jan 19 2026
Press Release Jan 19 2026
Nov 6 2025
Press Release Nov 05 2025
Financials
Revenue
₹37.2 B
Market Cap
₹158 B
P/E Ratio
45.08
EPS
8.72